Alan Lotvin - 03 Aug 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: EVP&President-PharmacyServices
Issuer ticker: CVS
Reported as of: 03 Aug 2022
Net transaction value: -$5,946,422
SEC form: 4
Accepted by SEC: 05 Aug 2022, 16:50:47 UTC
Prior SEC filing: 13 Jul 2022
Next SEC filing: 03 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Alan M. Lotvin

Key filing fact

Alan Lotvin filed Form 4 for CVS HEALTH Corp (CVS) on 05 Aug 2022.

Key facts

This page summarizes Alan Lotvin's Form 4 filing for CVS HEALTH Corp (CVS).
9 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 05 Aug 2022, 16:50.

Change

Previous filing in this sequence was filed on 13 Jul 2022.
Current net transaction value: -$5,946,422.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Options Exercise

Transaction value: $4,107,019
Shares: +70,398
Change %: +64%
Price: $58.34
Shares after: 179,581
Date: 03 Aug 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $6,899,004
Shares: -70,398
Change %: -39%
Price: $98.00
Shares after: 109,183
Date: 03 Aug 2022
Ownership: Direct
Footnotes: F1

CVS transaction

Common Stock

Options Exercise

Transaction value: $2,736,649
Shares: +50,501
Change %: +46%
Price: $54.19
Shares after: 159,684
Date: 03 Aug 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $4,949,098
Shares: -50,501
Change %: -32%
Price: $98.00
Shares after: 109,183
Date: 03 Aug 2022
Ownership: Direct
Footnotes: F1

CVS transaction

Common Stock

Options Exercise

Transaction value: $1,402,276
Shares: +22,541
Change %: +21%
Price: $62.21
Shares after: 131,724
Date: 04 Aug 2022
Ownership: Direct

CVS transaction

Common Stock

Sale

Transaction value: $2,344,264
Shares: -22,541
Change %: -17%
Price: $104.00
Shares after: 109,183
Date: 04 Aug 2022
Ownership: Direct
Footnotes: F1

CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 492
Date: 03 Aug 2022
Ownership: By Children's Trusts

CVS holding

Common Stock (restricted)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,827
Date: 03 Aug 2022
Ownership: Direct

CVS holding

Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,177
Date: 03 Aug 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -70,398
Change %: -50%
Price: $0.000000
Shares after: 70,399
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,398
Exercise price: $58.34
Footnotes: F2, F3

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -50,501
Change %: -71%
Price: $0.000000
Shares after: 20,201
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,501
Exercise price: $54.19
Footnotes: F4

CVS transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -22,541
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,541
Exercise price: $62.21
Footnotes: F5

CVS holding Derivative

Phantom Stock Credits

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 554
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 554
Exercise price: $1.00
Footnotes: F6, F7

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,395
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,395
Exercise price: $104.82
Footnotes: F8

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,911
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,911
Exercise price: $78.05
Footnotes: F9

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 120,940
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 120,940
Exercise price: $74.30
Footnotes: F10

CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 77,962
Date: 03 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 77,962
Exercise price: $101.09
Footnotes: F11

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

All sales were effected pursuant to a Rule 10b5-1 plan.

Footnote F2

The number of shares subject to the option were calculated using a 30-day average price.

Footnote F3

Option became exercisable in four equal annual installments, commencing 4/1/2021.

Footnote F4

Option became exercisable in four equal annual installments, commencing 4/1/2020.

Footnote F5

Option became exercisable in four equal annual installments, commencing 4/1/2019.

Footnote F6

Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

Footnote F7

Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

Footnote F8

Option became exercisable in four equal annual installments, commencing 4/1/2017.

Footnote F9

Option became exercisable in four equal annual installments, commencing 4/3/2018.

Footnote F10

Option became exercisable in four equal annual installments, commencing 4/1/2022.

Footnote F11

Option becomes exercisable in four equal annual installments, commencing 4/1/2023.